MedTrace Logo

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

NCT01415167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1690

Last updated 2019-06-13

No results posted yet for this study

Summary

The purpose of this registry is to collect information on patients who are receiving treatment with Proleukin in an organized way, and to learn more about patient care during and after treatment.

Conditions

Sponsors & Collaborators

  • Prometheus Laboratories

    lead INDUSTRY

Principal Investigators

  • Michael Wong, MD · MD Anderson

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2018-04-30
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415167 on ClinicalTrials.gov